Stan Berenshteyn
Stock Analyst at Wells Fargo
(2.14)
# 2,954
Out of 5,042 analysts
67
Total ratings
52.63%
Success rate
-8.78%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Stan Berenshteyn
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VEEV Veeva Systems | Maintains: Overweight | $326 → $341 | $293.02 | +16.37% | 8 | Aug 28, 2025 | |
| HCAT Health Catalyst | Maintains: Overweight | $10 → $6 | $3.22 | +86.34% | 6 | Aug 11, 2025 | |
| DOCS Doximity | Maintains: Equal-Weight | $62 → $65 | $66.84 | -2.75% | 12 | Aug 8, 2025 | |
| AMWL American Well | Maintains: Overweight | $15 → $12 | $5.57 | +115.44% | 4 | Aug 7, 2025 | |
| OMCL Omnicell | Maintains: Overweight | $37 → $40 | $31.08 | +28.70% | 17 | Jul 21, 2025 | |
| TDOC Teladoc Health | Maintains: Equal-Weight | $10 → $8 | $9.46 | -15.43% | 3 | May 8, 2025 | |
| GDRX GoodRx Holdings | Maintains: Overweight | $8 → $7 | $3.95 | +77.22% | 8 | Apr 29, 2025 | |
| HQY HealthEquity | Maintains: Overweight | $110 → $125 | $96.50 | +29.53% | 9 | Feb 26, 2025 |
Veeva Systems
Aug 28, 2025
Maintains: Overweight
Price Target: $326 → $341
Current: $293.02
Upside: +16.37%
Health Catalyst
Aug 11, 2025
Maintains: Overweight
Price Target: $10 → $6
Current: $3.22
Upside: +86.34%
Doximity
Aug 8, 2025
Maintains: Equal-Weight
Price Target: $62 → $65
Current: $66.84
Upside: -2.75%
American Well
Aug 7, 2025
Maintains: Overweight
Price Target: $15 → $12
Current: $5.57
Upside: +115.44%
Omnicell
Jul 21, 2025
Maintains: Overweight
Price Target: $37 → $40
Current: $31.08
Upside: +28.70%
Teladoc Health
May 8, 2025
Maintains: Equal-Weight
Price Target: $10 → $8
Current: $9.46
Upside: -15.43%
GoodRx Holdings
Apr 29, 2025
Maintains: Overweight
Price Target: $8 → $7
Current: $3.95
Upside: +77.22%
HealthEquity
Feb 26, 2025
Maintains: Overweight
Price Target: $110 → $125
Current: $96.50
Upside: +29.53%